Opinion · 29 Nov 2025
Conference abstractPublished 21 Jun 2017
Gram-negative bacterial phagelysates in anticancer therapy
Tbilisi State Medical University, Georgia Eliava Institute, Georgia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Application of bacterial preparations for anticancer immunomodulation is one of the promising ways of immunotherapy. Our experimental studies have shown high immunogenicity and less toxicity of E. coli and P. aeruginosa phagelysates than bacterial thermolysates. We were aimed to investigate antitumor immunomodulatory and adjuvant potential of Gram-negative bacterial phagelysates in cancer-bearing mice. Phage lysate of E. coli-Shigella specific Un bacteriophage was obtained by propagation of EcUnphage in semisynthetic medium and tested for: Sterility, viable bacterial cell content (CFU/ml), phage particles (PFU/ml), optical density (600 nm), protein concentration (Bradford method), endotoxins (LAL tests) and safety. Treatment effects (E. coli-Un phage lysate vaccinations 0.25 ml/day; Cyclophosphan 800 mg/m2) in Ehrlich carcinoma-bearing C57BL/6J mice were estimated by: index of malignant growth (using semi-empirical mathematical model V=Vo{exp[(t-to)/T]-1}; cancer growth inhibition percent; CD3CD4, CD3CD8, CD25Foxp3, NK-cells, IL-12, IFN-Ã?³, TGF-Ã?² (using FACS-Array Bioanalyzer, BD-FACSCalibur, USA, WST-8 Cell-Proliferation Assay-Kit; ELISA according to manufactures protocol, R&D-systems). It was observed that E. coli-Un phage lysate vaccinations are well tolerated in mice. Chemotherapy inhibited cancer growth, but no increase in lifespan was observed. Phagelysates significantly increased efficacy of chemotherapy. Cancer development was inhibited by 80âÂ?Â?90%. In 13%-19% of mice with 250-450 mm3 cancers complete regression of tumors was detected. Increase in Tc-effectors and cytokines and decrease in T-regs indicate E. coli-Un phage lysate anticancer immunomodulatory and adjuvant potential. It can be concluded that bacterial phage lysates can be used as powerful adjuvant in anticancer therapy.
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medical Microbiology & Diagnosis.
Commentary · 29 Nov 2025
Microbiology's Role In Infection Control and Prevention
Opinion · 29 Nov 2025
Antimicrobial Resistance in Urinary Tract Infections: A Growing Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Microbiology & Diagnosis
- SubjectMicrobiology
- BylineArticles whose byline prints “K Gambashidze”
- BylineArticles whose byline prints “A Sepashvili”
- BylineArticles whose byline prints “P Khorava”
- BylineArticles whose byline prints “T Azaladze”
- BylineArticles whose byline prints “E Jaiani”
- BylineArticles whose byline prints “B Lasareishvili”
- BylineArticles whose byline prints “M Tediashvili”

